For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Boston Medical Center Corporation

USPTO Granted Patents = 61

CIPO Patents = 2

EPO Patents = 7

Trademarks = 12

Forward Citations = 175

Loading Chart...

Loading Chart...

90 inventors (with patents filed for the assignee):

David H Sherr (8 out of 9 patents)

John R Murphy (7 out of 16 patents)

George J Murphy (6 out of 8 patents)

4. Sarah S Rozelle (6 out of 6 patents)

5. Brenden W Smith (6 out of 6 patents)

6. David J Salant (6 out of 6 patents)

7. Hernan Jara (5 out of 6 patents)

8. Weining Lu (5 out of 5 patents)

9. Xueping Fan (5 out of 5 patents)

10. Victoria Bolotina (4 out of 4 patents)

11. Diane P Williams (4 out of 11 patents)

12. Mark W Grinstaff (3 out of 56 patents)

13. Stephen Berasi (3 out of 8 patents)

14. Janet Elizabeth Buhlmann (3 out of 6 patents)

15. Nathan Higginson-Scott (3 out of 17 patents)

Core Competencies:

Nucleoside Modified mRNA

Tissue Markers

Red Blood Cell Production

Kidney Injury Treatment

Recombinant ROBO2 Proteins

Parkinson's Disease Biomarkers

Optical Coherence Tomography

Aryl Hydrocarbon Receptor Modifiers

Stem Cell Derivation

Diabetic Eye Disease Treatment

Mycobacterium Tuberculosis Diagnosis

Filovirus Infection Treatment

61 patents: Sort by Forward Citations

1. 12371666 - Nucleoside modified mRNA and uses thereof (2025-07-29),

2. 12310800 - Injection applicator for tissue markers (2025-05-27),

3. 12173320 - Production of red blood cells and platelets from stem cells (2024-12-24),

4. 12018058 - Compositions and methods for diagnosing and/or treating kidney injury (2024-06-25),

5. 11970524 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2024-04-30),

6. 11883246 - Tissue markers and uses thereof (2024-01-30),

7. 11788065 - Human iPSC-based derivation of NK and T-cells using early Notch induction (2023-10-17),

8. 11467158 - BRCA1 mutations as predictive markers for topoisomerase inhibitions (2022-10-11),

9. 11464844 - Methods and compositions using highly conserved pneumococcal surface proteins (2022-10-11),

10. 11375918 - White matter fibrography by synthetic magnetic resonance imaging (2022-07-05),

11. 11365253 - Anti-ROBO2 antibodies, compositions, methods and uses thereof (2022-06-21),

12. 11360102 - Biomarkers for the early detection of Parkinson's disease (2022-06-14),

13. 11337586 - Retractable endoscopic suction tube (2022-05-24),

14. 11324799 - Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease (2022-05-10),

15. 11136363 - Compositions and methods for diagnosing and/or treating kidney injury (2021-10-05),

Boston Medical Center (BMC) is a private, non-profit 514-bed academic medical center in Boston, Massachusetts. It is the largest safety-net hospital and Level I trauma center in New England.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

61 Patents

#43 in Boston, MA

#325 in Massachusetts

#5,749 in US

#11,629 in the World

Boston, MA, United States of America

Boston Medical Center Corporation

Forward Citations = 175

90 inventors:

David H Sherr (8 out of 9 patents)

John R Murphy (7 out of 16 patents)

George J Murphy (6 out of 8 patents)

4. Sarah S Rozelle (6 out of 6 patents)

5. Brenden W Smith (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…